"ovarian origin" trang 15 - tải miễn phí từ tailieunhanh
Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma

Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma
11    33    3
Two novel prognostic models for ovarian cancer respectively based on ferroptosis and necroptosis

Two novel prognostic models for ovarian cancer respectively based on ferroptosis and necroptosis
13    58    3
Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma

Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
10    37    3
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome

A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome
22    9    1
Uptake of exogenous estrogen as a differential diagnosis of ovarian-remnantsyndrome in a bitch: A case report

Uptake of exogenous estrogen as a differential diagnosis of ovarian-remnantsyndrome in a bitch: A case report
5    16    1
Progesterone-responsive vaginal leiomyoma and hyperprogesteronemia due to ovarian luteoma in an older bitch

Progesterone-responsive vaginal leiomyoma and hyperprogesteronemia due to ovarian luteoma in an older bitch
7    13    1
Summary of medical doctoral thesis: Research on the value of tumor marker CA125 and HE4 in diagnosis stage and treatment ovarian cancer

Summary of medical doctoral thesis: Research on the value of tumor marker CA125 and HE4 in diagnosis stage and treatment ovarian cancer
28    19    1
The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumorsuppressive immunomodulatory transcripts

The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumorsuppressive immunomodulatory transcripts
20    22    1
Postoperative pulmonary complications and outcomes in cytoreductive surgery for ovarian cancer: A propensity-matched analysis

Postoperative pulmonary complications and outcomes in cytoreductive surgery for ovarian cancer: A propensity-matched analysis
9    20    1
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer

Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
18    23    1
Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin

Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin
15    22    1
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
15    26    1
Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis
7    18    1
Nomograms to predict the prognosis in malignant ovarian germ cell tumors: A large cohort study

Nomograms to predict the prognosis in malignant ovarian germ cell tumors: A large cohort study
11    16    1
NAP1L1 promotes tumor proliferation through HDGF/C-JUN signalling in ovarian cancer

NAP1L1 promotes tumor proliferation through HDGF/C-JUN signalling in ovarian cancer
10    5    1
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer
10    18    1
Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: A network meta-analysis

Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: A network meta-analysis
10    10    1
Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study

Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study
15    20    1
Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs)

Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs)
13    21    1
Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer

Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
9    25    1